BackFrazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Total Liabilities

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s total liabilities is $12M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$12.21M
47.68% YoYΔ $3.94M vs prior year quarter

Peer average

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Total Liabilities History

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) vs. peers: Total Liabilities Comparison

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War) (FLACU) FAQ

The latest total liabilities for FLACU is $12M as of September 2022. That compares with $8.3M in the prior-year period — up 47.7% year over year. Investors often review this figure alongside Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, FLACU's total liabilities moved from $8.3M to $12M — a 47.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Frazier Lifesciences Acquisition - Units (1 Ord Share Class A & 1/3 War)'s operating scale or balance-sheet position.

A total liabilities figure of $12M for FLACU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FLACU's total liabilities ($12M), review year-over-year change from $8.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.